Although the revenue and EPS for Maximus (MMS) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Maximus (MMS) reported $1.33 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 6.2%. EPS of $1.34 for the same period compares to $0.94 a year ago.
The reported revenue represents a surprise of +3.49% over the Zacks Consensus Estimate of $1.28 billion. With the consensus EPS estimate being $1.28, the EPS surprise was +4.69%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Maximus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- U.S. Federal Services: $677.08 million versus the three-analyst average estimate of $628.18 million. The reported number represents a year-over-year change of +9.5%.
- Revenue- U.S. Services: $489.85 million versus the three-analyst average estimate of $484.97 million. The reported number represents a year-over-year change of +11.5%.
- Revenue- Outside the U.S: $160.12 million versus $170.90 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -16.4% change.
View all Key Company Metrics for Maximus here>>>
Shares of Maximus have returned +1.6% over the past month versus the Zacks S&P 500 composite's +5.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
*Zacks Names "Single Best Pick to Double"
*From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
*It’s credited with a "watershed medical breakthrough" and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. This is a timely investment that you can catch while it emerges from its bear market lows.
*It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Maximus, Inc. (MMS): Free Stock Analysis ReportTo read this article on Zacks.com click here.
Zacks Investment Research
credit=zacks